For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...